Critical evaluation of the claims made by pharmaceutical companies in drug promotional material in Pakistan

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 9, Issue 1, 2006, Pages 50-59

  Rohra, Dileep Kumar ^a   Gilani, Anwarul Hassan ^a   Memon, Ismail Kamal ^a   Perven, Ghazala ^b   Khan, Muhammad Talha ^b   Zafar, Hina ^b   Kumar, Rakesh ^c  

^a AGA KHAN UNIVERSITY   (Pakistan)

^b DOW UNIVERSITY OF HEALTH SCIENCES   (Pakistan)

^c JINNAH POSTGRADUATE MEDICAL CENTRE   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

AJMALICINE PLUS ALMITRINE; ALFACALCIDOL; ALPHA TOCOPHEROL; AMOXICILLIN; ATENOLOL; BETAHISTINE; BROMAZEPAM; BUCLIZINE; CALCIUM; DOMPERIDONE; FAMOTIDINE; FOSFOMYCIN; FURAZOLIDONE; GLIBENCLAMIDE; GLIMEPIRIDE; HYDROCORTISONE SODIUM SUCCINATE; LACTULOSE; LANSOPRAZOLE; LISINOPRIL; LIV 52; LORATADINE; LOSARTAN; MECOBALAMIN; METHOTREXATE; METOCLOPRAMIDE; METRONIDAZOLE; NIMODIPINE; ORNITHINE ASPARTATE; PSEUDOMONIC ACID; RANITIDINE; UNINDEXED DRUG;

ADULT; AMBIGUITY; ANALYTIC METHOD; ARTICLE; CLASSIFICATION; CONTROLLED STUDY; DRUG INDUSTRY; DRUG INFORMATION; DRUG MARKETING; EVIDENCE BASED MEDICINE; FEMALE; GENERAL PRACTITIONER; HOSPITAL PHYSICIAN; HUMAN; MALE; MEDICAL AUDIT; MEDICAL LITERATURE; PAKISTAN; PRESCRIPTION; SCIENTIFIC LITERATURE;

ADVERTISING; DRUG INDUSTRY; DRUG INFORMATION SERVICES; DRUG LABELING; ETHICS, PHARMACY; PAKISTAN; PAMPHLETS; PRESCRIPTIONS, DRUG;

EID: 32944475619     PISSN: 14821826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Anonymous., Can the advertisements in a reputable medical journal promote quackery? J. Am. Med. Assoc, 22: 958, 1894.
2. Criteria for Medicinal Drug Promotion, World Health Organisation. Endorsed by the 33rd World Health Assembly, May 1986, Resolution No. WHA21.41.
3. Levy, R., The role and value of pharmaceutical marketing. Arch. Fam. Med, 3(4): 327-332, 1994.
4. Gutknecht, D.R., Evidence-based advertising? A survey of four major journals. J. Am. Board Fam. Pract, 14(3): 197-200, 2001.
5. Villanueva, P.; Peiró, S.; Librero, J. and Pereiró, I., Accuracy of pharmaceutical advertisements in medical journals. Lancet, 361(9351): 27-32, 2003.
6. Avorn, J.; Chen, M. and Hartley, R., Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am. J. Med, 73(1): 4-8, 1982.
7. Lober, C.W., Ethics in pharmaceutical marketing. Dermatol. Clin, 11(2): 285-288, 1993.
8. Caudill, T.S.; Johnson, M.S.; Rich, E.C. and McKinney, W.P., Physicians, pharmaceutical sales representatives, and the cost of prescribing. Arch. Fam. Med, 5(4): 201-206, 1996.
9. Haayer, F., Rational prescribing and sources of information. Soc. Sci. Med, 16(23): 2017-2023, 1982.
10. Jones, M.I.; Greenfield, S.M. and Bradley, C.P., Prescribing new drugs: qualitative study of influences on consultants and general practitioners. Br. Med. J, 323(7309): 378-381, 2001.
11. Lexchin, J., How patient outcomes are reported in advertisements: review of Canadian medical journals. Can. Fam. Physician, 45: 1213-1216, 1999.
12. Loke, T.W.; Koh, F.C. and Ward, J.E., Pharmaceutical advertisement claims in Australian medical publications. Med. J. Aust, 177(6): 291-293, 2002.
13. Waxman, H.A., Ensuring that consumers receive appropriate information from drug ads: what is the FDA's role? Health Aff (millwood), W4: 256-258, 2004.
14. Verster, J.C. and Volkerts, E.R., Antihistamines and driving ability: evidence from on-the-road driving studies during normal traffic. Ann. Allergy Asthma Immunol, 92(6): 294-303, 2004.
15. Richy, F.; Ethgen, O.; Bruyere, O. and Reginster, J.Y., Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate. Osteoporos Int, 15(4): 301-310, 2004.
16. Lamy, F., Appetite stimulation and weight increase with buclizine. Brux. Med, 51(4): 287-290, 1971.
17. Barone, J.A., Domperidone: a peripherally acting dopamine2-receptor antagonist. Ann. Pharmacother, 33(4): 429-440, 1999.
18. Milo, R., Use of the peripheral dopamine antagonist, domperidone, in the management of gastrointestinal symptoms in patients with irritable bowel syndrome. Curr. Med. Res. Opin, 6(9): 577-584, 1980.
19. Poitrenaud, J.; Piette, F.; Malbezin, M.; Sebban, C. and Guez, D., Duxil and cognitive deficiency in the elderly. Results of a 6-month controlled multicenter study. Ann. Med. Interne (Paris), 141(Suppl 1): 31-35, 1990.
20. Sonnenberg, G.E.; Garg, D.C.; Weidler, D.J.; Dixon, R.M.; Jaber, L.A.; Bowen, A.J.; DeChemey, G.S.; Mullican, W.S. and Stonesifer, L.D., Short-term comparison of once- versus twice-daily administration of glimepiride in patients with non-insulin-dependent diabetes mellitus. Ann. Pharmacother, 31(6): 671-676, 1997.
21. Ellis, A.K. and Day, J.H., Diagnosis and management of anaphylaxis. Can. Med. Assoc. J, 169(4): 307-312, 2003.
22. Kircheis, G.; Wettstein, M.; Dahl. S. and Haussinger, D., Clinical efficacy of L-ornithine-L-aspartate in the management of hepatic encephalopathy. Metab. Brain. Dis, 17(4): 453-462, 2002.
23. Zhu, X.P. and Zhou, Z.G., Clinical observation of combined therapeutic effect of prostaglandin El and mecobalamin on diabetic peripheral neuropathy. Hunan. Yi. Ke. Da. Xue. Xue. Bao, 26(4): 343-344, 2001.
24. Lopez-Arrieta, J.M. and Birks, J., Nimodipine for primary degenerative, mixed and vascular dementia. Cochrane. Database Syst. Rev, 3: CD000147, 2002.
25. Riley, J.D. and Antony, S.J., Leg cramps: differential diagnosis and management. Am Fam Physician, 52(6): 1794-1798, 1995.
26. Mabadeje, A.F. and Adebayo, G.I., Comparative effects of labetalol and bromazepam on ambulatory blood pressure of Nigerians with labile and stress hypertension. Clin. Exp. Hypertens. A, 11(Suppl 1): 441-447, 1989.
27. van Zyl, A.I.; Jennings, A.A.; Bateman, E.D. and Opie, L.H., Comparison of respiratory effects of two cardioselective beta-blockers, celiprolol and atenolol, in asthmatics with mild to moderate hypertension. Chest, 95(1): 209-213, 1989.
28. Ottosson, A.; Jansen, I. and Edvinsson, L., Characterization of histamine receptors in isolated human cerebral arteries. Br. J. Pharmacol, 94(3): 901-907, 1988.
29. Fujino, A.; Tokumasu, K.; Yosio, S.; Naganuma, H.; Yoneda, S. and Nakamura, K., Vestibular training for benign paroxysmal positional vertigo. Its efficacy in comparison with antivertigo drugs. Arch, Otolaryngol, Head Neck Surg, 120(5): 497-504, 1994.
30. Morikawa, K.; Nonaka, M.; Yoshikawa, Y. and Torii, I., Synergistic effect of fosfomycin and arbekacin on a methicillin-resistant Staphylococcus aureus-induced biofilm in a rat model. Int. J. Antimicrob. Agents, 25(1): 44-50, 2005.
31. Haustein, UF. and Rytter, M., Methotrexate in psoriasis: 26 years' experience with low-dose long-term treatment. J. Eur. Acad. Dermatol. Venereol, 14(5): 382-388, 2000.
32. Themido, R.; Loureiro, M.; Pecegueiro, M.; Brandao, M. and Campos, MC.,. Methotrexate hepatotoxicity in psoriatic patients submitted to long-term therapy. Acta. Derm. Venereol, 72(5): 361-364, 1992.
33. Hoekstra, M.; van Ede, A.E.; Haagsma, C.J.; van de Laar, M.A.; Huizinga, T.W.; Kruijsen, M.W. and Laan, R.F., Factors associated with toxicity, final dose, and efficacy of methotrexate in patients with rheumatoid arthritis. Ann. Rheum. Dis, 62(5): 423-426, 2003.
34. Lewis, J.H., The rational use of potentially hepatotoxic medication in patients with underlying liver disease. Expert Opin, Drug Saf, 1(2): 159-172, 2002.
35. Perucca, E., Drug interactions with nimesulide. Drugs, 46 Suppl 1: 79-82, 1993.
36. Phillips, I. and Shannon, K., The activity of cephalosporins on beta-lactamase-producing Neisseria gonorrhoeae. Scand. J. Infect. Dis, 13: 23-26, 1978.
37. Nielsen, P.N.; Skov, P.S.; Poulsen, L.K.; Schmelz, M. and Petersen, L.J., Cetirizine inhibits skin reactions but not mediator release in immediate and developing late-phase allergic cutaneous reactions. A double-blind, placebo-controlled study. Clin. Exp. Allergy, 31(9): 1378-1384, 2001.
38. Kukoyi, O.; Argo, T.R. and Carnahan, R.M., Exacerbation of panic disorder with rifampin therapy in a patient receiving citalopram. Pharmacotherapy, 25(3): 435-437, 2005.
39. Cohen, R.A.; Browndyke, J.N.; Moser, D.J.; Paul, R.H.; Gordon, N. and Sweet, L., Long-term citicolin (cytidine diphosphate choline) use in patients with vascular dementia: neuroimaging and neuropsychological outcomes. Cerebrovasc. Dis, 16(3): 199-204, 2003).
40. Zweifler, R.M., Membrane stabilizer: citicoline. Curr. Med. Res. Opin, 18 (Suppl 2): s14-17, 2002.
41. Mannucci, E.; Monami, M.; Masotti, G. and Marchionni, N., All-cause mortality in diabetic patients treated with combinations of sulfonylureas and biguanides. Diabetes Metab. Res. Rev, 20(1): 44-47, 2004.
42. Olsson, J.; Lindberg, G.; Gottsater, M. Lindwall, K.; Sjostrand, A.; Tisell, A. and Melander A., Increased mortality in Type II diabetic patients using sulphonylurea and metformin in combination: a population-based observational study. Diabetologia, 43(5): 558-560, 2000.
43. Mroz, P.J. and Silbert, J.E., Effects of [3H]glucosamine concentration on [3H]chondroitin sulphate formation by cultured chondrocytes. Biochem. J, 376(Pt 2): 511-515, 2003.
44. Nishimura, T.; Hashimoto, J.; Ohkubo, T.; Kikuya, M.; Metoki, H.; Asayama, K.; Totsune, K. and Imai, Y., Efficacy and duration of action of the four selective angiotensin II subtype I receptor blockers, losartan, candesartan, valsartan and telmisartan, in patients with essential hypertension determined by home blood pressure measurements. Clin. Exp. Hypertens, 27(6): 477-489, 2005.
45. Goettsch, W.G.; van den Boom, G.; Breekveldt-Postma, N.S.; Smout, A.J. and Herings, R.M., Treatment patterns and health care costs of mebeverine-treated IBS patients: a case-control study. Pharmacoepidemiol. Drug Saf, 13(11): 803-810, 2004.
46. Schattner, A.; Sokolovskaya, N. and Cohen, J., Fatal hepatitis and renal failure during treatment with nimesulide. Intern. Med, 247(1): 153-155, 2000.
47. Cho Lee, A.R.; Leem, H.; Lee, J. and Park, K.C., Reversal of silver sulfadiazine-impaired wound healing by epidermal growth factor. Biomaterials, 26(22): 4670-4676, 2005.
48. Ahmad, S.R. and Bhutta, Z.A., A survey of paediatric prescribing and dispensing in Karachi. J. Pak. Med. Assoc, 40(6): 126-130, 1990.
49. Gambrill, J. and Bridges-Webb, C., Use of sources of therapeutic and prescribing information by general practitioners. Aust. Fam. Physician, 9(7): 482-484, 1980.